On February 1, 2022, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55 JPY | -9.84% | -9.84% | -36.78% |
1st Jan change | Capi. | |
---|---|---|
-36.78% | 27.4M | |
+34.01% | 51.07B | |
+34.69% | 38.61B | |
-8.02% | 38.78B | |
-8.98% | 27.32B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥1.427175 billion in funding from Macquarie Bank Limited, Investment Arm